Bioactivity of new AmB-PMA nanoparticle in prophylaxis and treatment of transplant-related invasive aspergillosis
Aspergillus species are opportunistic mould pathogens that can cause a wide variety of pulmonary diseases. They are mainly caused by Aspergillus fumigatus (Munoz et al., 2006). Germination of conidia in hosts with a susceptible immune system is the first step in Aspergillus infection, and invasive a...
Main Author: | Shirkhani, Khojasteh |
---|---|
Other Authors: | Shaunak, Sunil; Armstrong-James, Darius |
Published: |
Imperial College London
2014
|
Subjects: | |
Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.656756 |
Similar Items
-
Invasive aspergillosis in solid organ transplant patients: diagnosis, prophylaxis, treatment, and assessment of response
by: Dionysios Neofytos, et al.
Published: (2021-03-01) -
Prophylaxis and treatment of invasive aspergillosis with voriconazole, posaconazole and caspofungin - review of the literature
by: Karthaus M
Published: (2011-04-01) -
Aerosolized amphotericin B as prophylaxis for invasive pulmonary aspergillosis: a meta-analysis
by: Di Xia, et al.
Published: (2015-01-01) -
The role of Aspergillus antigens and specific anti-Aspergillus antibodies in the diagnosis of invasive aspergillosis
by: Haynes, Kenneth Adrian
Published: (1991) -
Standards in prophylaxis: Prevention of invasive aspergillosis in patients with hematologic malignancies
by: D. Kontoyiannis
Published: (2014-04-01)